ArisGlobal has opened up new opportunities for clinical trial sponsors to use agDisclosure to meet trial registration and disclosure requirements at no cost.
ArisGlobal, a leading provider of solutions to the life science industry has opened up new opportunities for clinical trial sponsors to use agDisclosureTM to meet trial registration and disclosure requirements at no cost. With the release of agDisclosure™ Basic Edition, the company offers a free, entry-level version of its full product in support of trial registration and results disclosure to ClinicalTrials.gov.
agDisclosure Basic Edition is the first and only cloud-based offering that gives life science organizations a no-cost way to efficiently manage the trial registration and results disclosure process for ClinicalTrials.gov. Planning and tracking as well as configurable review and approval workflow functionality ensure the quality, consistency and integrity of data before it is submitted. Pre-recorded training and a user guide enable users to become productive quickly. Interested companies can learn more about this free version at http://totalclinical.com/agdisclosure-free-basic-edition.
“While there are good reasons for making the disclosure of protocol and results data mandatory, the increasing transparency requirements add to the administrative burdens around conducting clinical trials,” states Mathias Poensgen, Product Manager, ArisGlobal. “agDisclosure helps to keep these administrative costs under control by making the trial registration and disclosure process as efficient as possible. Using agDisclosure Basic Edition, companies can experience and evaluate the value this solution delivers over managing the disclosure process manually or using an in-house solution at no cost to their organization.”
The Basic Edition is an entry-level version of the agDisclosure Enterprise Edition, an extended solution that supports trial registration and results reporting to ClinicaTrials.gov, EudraCT and other global registries. The Enterprise Edition, (offered either on premise or hosted on the cloud), provides fuller functionality, including the ability to re-use one entry multiple times across different registries and seamless integration with any CTMS.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.